Corbus Pharmaceuticals Holdings, Inc.
Price Action
Technical Summary
WEAKENINGCorbus Pharmaceuticals Holdings, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 31), showing significant lag compared to the market leaders. Earnings contraction of 24% provides fundamental context to the price action. Investors should exercise caution due to high volatility (82% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $7.98 | +9.58% | ABOVE |
| 50 SMA | $9.38 | -6.78% | BELOW |
| 100 SMA | $9.05 | -3.47% | BELOW |
| 150 SMA | $9.11 | -4.11% | BELOW |
| 200 SMA | $10.20 | -14.28% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CRBP in an uptrend right now?
CRBP has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is CRBP overbought or oversold?
CRBP's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.
Is CRBP outperforming the market?
CRBP has a Relative Strength (RS) Rating of 31 out of 99. CRBP is currently lagging the broader market.
Where is CRBP in its 52-week range?
CRBP is trading at $8.74, which is 43% of its 52-week high ($20.56) and 15% above its 52-week low ($6.72).
How volatile is CRBP?
CRBP has a Beta of 1.05 and 52-week volatility of 82%. It's more volatile than the S&P 500 - expect bigger swings.